Skip to main content
. 2017 Nov 15;8(61):103283–103289. doi: 10.18632/oncotarget.22464

Figure 1. Expression of NY-ESO-1 antigen in iCCA and corresponding adjacent normal tissues.

Figure 1

(A–D) Representative H&E staining demonstrate the well (A) and poorly (C) differentiated iCCA tissues; Immunohistochemical micrographs show the expression of NY-ESO-1 in well (B) and poorly (D) differentiated carcinoma (Original magnification: × 400). (E, F) NYESO-1 antigen expression was significantly increased in iCCA tissue, especially in tissues with stage III and IV disease, compared with that in adjacent non-neoplastic tissues (E, F). (AT: adjacent tissues.)